Deferred Tax Assets, Valuation Allowance in USD of PSYCHEMEDICS CORP from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PSYCHEMEDICS CORP quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2020 to Q4 2024.
  • PSYCHEMEDICS CORP Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $2,660,000, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PSYCHEMEDICS CORP Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $2,660,000 +$81,000 +3.1% 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q4 2023 $2,579,000 +$1,684,000 +188% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $692,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q4 2022 $895,000 +$481,000 +116% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $414,000 +$414,000 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q4 2020 $0 31 Dec 2020 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.